{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:46:54Z","timestamp":1792007214029,"version":"4.4.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bmc.2024.117899","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T15:33:38Z","timestamp":1725032018000},"page":"117899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Design, classification, and adverse effects of NSAIDs: A review on recent advancements"],"prefix":"10.1016","volume":"112","author":[{"given":"Minhajul","family":"Arfeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliman A.","family":"Almahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-6790","authenticated-orcid":false,"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117899_b0005","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2024.117899_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jot.2017.05.007","article-title":"Inflammation and its resolution and the musculoskeletal system","volume":"10","author":"Gallo","year":"2017","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.bmc.2024.117899_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0020","article-title":"Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in cancer prevention and cancer promotion","volume":"2019","author":"Wong","year":"2019","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.bmc.2024.117899_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113493","article-title":"Contemporary advances of cyclic molecules proposed for inflammation","volume":"221","author":"Neha","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/0929867003374219","article-title":"Cyclooxygenase-2 inhibition and side-effects of non-steroidal antiinflammatory drugs in the gastrointestinal tract","volume":"7","author":"Meyer-Kirchrath","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0035","article-title":"Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review","volume":"15","author":"Sohail","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bmc.2024.117899_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40266-019-00664-x","article-title":"Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis","volume":"36","author":"Curtis","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bmc.2024.117899_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13090209","article-title":"Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach","volume":"13","author":"Le\u00e3o","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2024.117899_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2024.117899_b0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0060","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2174\/092986710793205408","article-title":"Selective COX-1 inhibition: a therapeutic target to be reconsidered","volume":"17","author":"Perrone","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2019.01.044","article-title":"The relatively selective cyclooxygenase-2 inhibitor nimesulide: what\u2019s going on?","volume":"848","author":"Caiazzo","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113566","article-title":"New nimesulide derivatives with amide\/sulfonamide moieties: selective COX-2 inhibition and antitumor effects","volume":"221","author":"G\u00fcng\u00f6r","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2019.03.042","article-title":"European journal of medicinal chemistry dioxide derivatives as potential selective COX-2 inhibitors","volume":"171","author":"Taher","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.03.052","article-title":"New pyrazole derivatives: synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of MPGES","volume":"171","author":"Hassan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112293","article-title":"Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates","volume":"196","author":"Panda","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113682","article-title":"Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential","volume":"224","author":"Said","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0095","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/acs.jmedchem.6b00134","article-title":"Rational design of small peptides for optimal inhibition of cyclooxygenase-2: development of a highly effective anti-inflammatory agent","volume":"59","author":"Singh","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109024","article-title":"Naproxenylamino acid derivatives: design, synthesis, docking, QSAR and anti-inflammatory and analgesic activity","volume":"116","author":"Elhenawy","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117899_b0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bioorg.2019.02.043","article-title":"Novel aryl carboximidamide and 3-aryl-1, 2, 4-oxadiazole analogues of naproxen as dual selective COX-2 \/ 15-LOX inhibitors: design, synthesis and docking studies","volume":"85","author":"Youssif","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0110","article-title":"Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors : sulfide, sulfoxide, and sulfone derivatives of 1, 5- diarylpyrrol-3-substituted scaffold","volume":"27","author":"Reale","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103023","article-title":"Design, synthesis, modeling studies and biological screening of novel pyrazole derivatives as potential analgesic and anti-inflammatory agents","volume":"89","author":"Taher","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115427","article-title":"Anti-Inflammatory effect and inhibition of nitric oxide production by targeting COXs and INOS enzymes with the 1,2-diphenylbenzimidazole pharmacophore","volume":"28","author":"Garc\u00eda-Aranda","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103540","article-title":"New pyrazole derivatives possessing amino \/ methanesulphonyl pharmacophore with good gastric safety profile : design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies","volume":"95","author":"Abdellatif","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104883","article-title":"Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors : implementation of apoptotic genes expression for ulcerogenic liability assessment","volume":"111","author":"Marzouk","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104168","article-title":"Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives","volume":"104","author":"Munir","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2020.00612","article-title":"In silico methods for drug design and discovery","volume":"8","author":"Brogi","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2013.10.083","article-title":"3D QSAR studies based in silico screening of 4,5,6-triphenyl-1,2,3,4- tetrahydropyrimidine analogs for anti-inflammatory activity","volume":"73","author":"Lokwani","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73203-z","article-title":"Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways","volume":"10","author":"das Chagas Pereira de Andrade","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117899_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128271","article-title":"Identification of potential human COX-2 inhibitors using computational modelling and molecular dynamics simulations","volume":"1216","author":"Beura","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117899_b0160","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1080\/07391102.2019.1664328","article-title":"In silico screening of anti-inflammatory compounds from lichen by targeting cyclooxygenase-2","volume":"38","author":"Joshi","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117899_b0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ddr.21753","article-title":"\u201cAzole\u201d as privileged heterocycle for targeting the inducible cyclooxygenase enzyme","volume":"82","author":"Prasher","year":"2021","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2024.117899_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103540","article-title":"Molecular modeling and structural analysis of some tetrahydroindazole and cyclopentanepyrazole derivatives as COX-2 inhibitors","volume":"15","author":"Polo-cuadrado","year":"2022","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0175","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/07391102.2020.1737574","article-title":"Identification of new potential cyclooxygenase-2 inhibitors: insight from high throughput virtual screening of 18 million compounds combined with molecular dynamic simulation and quantum mechanics","volume":"39","author":"Heidarpoor Saremi","year":"2021","journal-title":"J Biomole Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117899_b0180","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/molecules24081476","article-title":"In silico evaluation of ibuprofen and two benzoylpropionic acid derivatives with potential anti-inflammatory activity","volume":"24","author":"Bittencourt","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117899_b0185","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1080\/07391102.2020.1785329","article-title":"Molecular insights into benzene sulphonamide substituted diarylpyrazoles as cyclooxygenase-2 inhibitor and its structural modifications","volume":"39","author":"Priya","year":"2021","journal-title":"J Biomole Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117899_b0190","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/07391102.2020.1823884","article-title":"Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids","volume":"40","author":"Taidi","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117899_b0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/08927022.2020.1764552","article-title":"Identification of promising compounds from curry tree with cyclooxygenase inhibitory potential using a combination of machine learning, molecular docking, dynamics simulations and binding free energy calculations","volume":"46","author":"Pandya","year":"2020","journal-title":"Mol Simul"},{"key":"10.1016\/j.bmc.2024.117899_b0200","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1021\/acs.jmedchem.0c00813","article-title":"Sila-Ibuprofen","volume":"63","author":"Kleemiss","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0205","doi-asserted-by":"crossref","first-page":"30108","DOI":"10.1021\/acsomega.1c04943","article-title":"Benzannulation and hydrocarboxylation methods for the synthesis of a neopentylene-fused analogue of ibuprofen","volume":"6","author":"Martin","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2024.117899_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105557","article-title":"Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates","volume":"119","author":"Ghanim","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0215","doi-asserted-by":"crossref","first-page":"31348","DOI":"10.1021\/acsomega.1c05222","article-title":"(Benzylideneamino)triazole\u2013thione derivatives of flurbiprofen: an efficient microwave-assisted synthesis and in vivo analgesic potential","volume":"6","author":"Zaheer","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2024.117899_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105856","article-title":"Synthesis and pharmacological evaluation of cvib, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent","volume":"76","author":"de Oliveira Pedrosa Rolim","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2016.09.005","article-title":"Novel 1,3,4-oxadiazole\/oxime hybrids: synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities","volume":"69","author":"Abd-Ellah","year":"2016","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0230","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2014.10.081","article-title":"Benzimidazole\u2013ibuprofen\/mesalamine conjugates: potential candidates for multifactorial diseases","volume":"89","author":"Bansal","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0235","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.bmc.2015.03.049","article-title":"Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic\/anti-inflammatory properties: synthesis, biological evaluation and molecular modeling studies","volume":"23","author":"Sarigol","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jmgm.2016.05.009","article-title":"Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: design, synthesis and molecular docking studies","volume":"67","author":"Azizian","year":"2016","journal-title":"J Mole Graph Modell"},{"key":"10.1016\/j.bmc.2024.117899_b0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2015.05.001","article-title":"Synthesis and biological evaluation of boswellic acid-NSAID hybrid molecules as anti-inflammatory and anti-arthritic agents","volume":"98","author":"Shenvi","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.02.122","article-title":"Synthesis and antinociceptive evaluation of bioisosteres and hybrids of naproxen, ibuprofen and paracetamol","volume":"101","author":"Gonz\u00e1lez-Trujano","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117899_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104300","article-title":"Identification of novel diclofenac acid and naproxen bearing hydrazones as 15-LOX inhibitors: design, synthesis, in vitro evaluation, cytotoxicity, and in silico studies","volume":"15","author":"Sardar","year":"2022","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0260","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/molecules28041945","article-title":"New NSAID conjugates as potent and selective COX-2 inhibitors: synthesis, molecular modeling and biological investigation","volume":"28","author":"Bokhtia","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117899_b0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2015.02.012","article-title":"Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation","volume":"752","author":"Pittal\u00e0","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molstruc.2019.03.020","article-title":"A new palladium(II) complex with ibuprofen: spectroscopic characterization, DFT studies, antibacterial activities and interaction with biomolecules","volume":"1186","author":"Fiori-Duarte","year":"2019","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117899_b0275","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100900","article-title":"Synthesis, antimicrobial evaluation, and molecular modeling studies of new thiosemicarbazide-triazole hybrid derivatives of (S)-naproxen","volume":"19","author":"Han","year":"2022","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2024.117899_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133391","article-title":"Synthesis, crystal structure, and a molecular modeling approach to identify effective antiviral hydrazide derivative against the main protease of SARS-CoV-2","volume":"1265","author":"Mohamed","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117899_b0285","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.bmcl.2017.05.071","article-title":"Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum","volume":"27","author":"Col\u00edn-Lozano","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"10.1016\/j.bmc.2024.117899_b0290","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.bmcl.2016.09.059","article-title":"1H-1,2,3-Triazolyl-substituted 1,3,4-oxadiazole derivatives containing structural features of ibuprofen\/naproxen: their synthesis and antibacterial evaluation","volume":"26","author":"Neeraja","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117899_b0295","first-page":"1","article-title":"Anxiolytic and anticonvulsant effect of ibuprofen derivative through GABAergic neuromodulation in adult zebrafish","author":"Rodrigues Garcia","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117899_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112997","article-title":"ROS-responsive and multifunctional anti-Alzheimer prodrugs: tacrine-ibuprofen hybrids via a phenyl boronate linker","volume":"212","author":"Liu","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0305","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bmc.2018.01.030","article-title":"Design, synthesis and evaluation of 4\u2032-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer\u2019s disease treatment","volume":"26","author":"Cao","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115374","article-title":"Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer\u2019s disease","volume":"28","author":"Yang","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0315","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.bmc.2024.117899_b0320","first-page":"435","article-title":"Analgesic and antipyretic natural products","volume":"55","author":"Shilpi","year":"2020","journal-title":"Ann Rep Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0325","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.lfs.2005.09.006","article-title":"Analgesic substances derived from natural products (natureceuticals)","volume":"78","author":"McCurdy","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2024.117899_b0330","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/15287394.2019.1711476","article-title":"Salix alba (white willow) medicinal plant presents genotoxic effects in human cultured leukocytes","volume":"82","author":"Maistro","year":"2019","journal-title":"J Toxic Environ Health A"},{"key":"10.1016\/j.bmc.2024.117899_b0335","first-page":"1","article-title":"The First 3500 years of Aspirin History from Its Roots \u2013 A Concise Summary","volume":"113","author":"Montinari","year":"2019","journal-title":"VascPharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0340","series-title":"Molecular insight of drug design","first-page":"3","article-title":"Integrated approach to nature as source of new drug lead","author":"Kohli","year":"2018"},{"key":"10.1016\/j.bmc.2024.117899_b0345","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/DDDT.S292826","article-title":"Synthesis of michael adducts as key building blocks for potential analgesic drugs. in vitro, in vivo and in silico explorations","volume":"15","author":"Ahmad","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2024.117899_b0350","first-page":"106","article-title":"HPLC analysis of salicylic derivatives from natural products","volume":"59","author":"Toiu","year":"2011","journal-title":"Farmacia"},{"key":"10.1016\/j.bmc.2024.117899_b0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389557513666131211110004","article-title":"Naturally occurring methyl salicylate glycosides","volume":"14","author":"Mao","year":"2014","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0360","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fitote.2017.05.001","article-title":"Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives","volume":"119","author":"He","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2024.117899_b0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1248\/bpb.26.365","article-title":"Tryptanthrin inhibits interferon-\u03b3 production by Peyer\u2019s patch lymphocytes derived from mice that had been orally administered staphylococcal enterotoxin","volume":"26","author":"Takei","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmc.2024.117899_b0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13659-016-0113-7","article-title":"(\u00b1)-Evodiakine, a pair of rearranged rutaecarpine-type alkaloids from evodia rutaecarpa","volume":"6","author":"Li","year":"2016","journal-title":"Nat Prod Bioprospect"},{"key":"10.1016\/j.bmc.2024.117899_b0375","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci"},{"key":"10.1016\/j.bmc.2024.117899_b0380","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/molecules25030762","article-title":"Therapeutic potential of flavonoids in pain and inflammation: mechanisms of action, pre-clinical and clinical data, and pharmaceutical development","volume":"25","author":"Ferraz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117899_b0385","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1089\/jmf.2006.255","article-title":"A medicinal extract of Scutellaria Baicalensis and Acacia Catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation","volume":"10","author":"Burnett","year":"2007","journal-title":"J Med Food"},{"key":"10.1016\/j.bmc.2024.117899_b0390","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.bmc.2024.117899_b0395","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biopha.2017.06.003","article-title":"An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances","volume":"92","author":"Zeinali","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117899_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2020.112272","article-title":"Essential oil and its nanoemulsion of araucaria heterophylla resin: chemical characterization, anti-inflammatory, and antipyretic activities","volume":"148","author":"Elshamy","year":"2020","journal-title":"Ind Crop Prod"},{"key":"10.1016\/j.bmc.2024.117899_b0405","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/s-2002-34403","article-title":"Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from dracaena loureiri","volume":"68","author":"Likhitwitayawuid","year":"2002","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2024.117899_b0410","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1055\/s-0030-1249779","article-title":"Anti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory, and free radical scavenging effects of Rumex Nepalensis","volume":"76","author":"Gautam","year":"2010","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2024.117899_b0415","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1055\/s-0035-1546242","article-title":"Inhibition of COX-2 and NF-\u039aB1 gene expression, NO production, 5-LOX, and COX-1 and COX-2 enzymes by extracts and constituents of onopordum acanthium","volume":"81","author":"Lajter","year":"2015","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2024.117899_b0420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s000110050512","article-title":"A new class of COX-2 inhibitor, rutaecarpine from evodia rutaecarpa","volume":"48","author":"Moon","year":"1999","journal-title":"Inflam Res"},{"key":"10.1016\/j.bmc.2024.117899_b0425","first-page":"649","article-title":"Nectandra amazonum-derived flavonoids as COX-1 inhibitors. In vitro and docking studies","volume":"9","author":"Vald\u00e9s-Barrera","year":"2014","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.bmc.2024.117899_b0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jep.2004.07.026","article-title":"A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of semecarpus anacardium","volume":"95","author":"Selvam","year":"2004","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0435","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/np100638h","article-title":"Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro","volume":"74","author":"Ho\u0161ek","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117899_b0440","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.lfs.2009.09.007","article-title":"Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity","volume":"85","author":"Srivastava","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2024.117899_b0445","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11418-018-1251-5","article-title":"Identification of \u03b2-carboline and canthinone alkaloids as anti-inflammatory agents but with different inhibitory profile on the expression of INOS and COX-2 in lipopolysaccharide-activated RAW 264.7 macrophages","volume":"73","author":"Liu","year":"2019","journal-title":"J Nat Med"},{"key":"10.1016\/j.bmc.2024.117899_b0450","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.lfs.2005.09.041","article-title":"Inhibitory effects of irigenin from the rhizomes of belamcanda chinensis on nitric oxide and prostaglandin E2 production in murine macrophage RAW 264.7 cells","volume":"78","author":"Ahn","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2024.117899_b0455","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.3390\/molecules190914667","article-title":"Anti-inflammatory and analgesic effects of the marine-derived compound comaparvin isolated from the crinoid comanthus bennetti","volume":"19","author":"Chen","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117899_b0460","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10787-017-0421-5","article-title":"Anti-inflammatory and anticancer activities of combretin a and combretin B isolated from combretum fragrans F. HOFFM (Combretaceae) leaves","volume":"26","author":"Mbiantcha","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bmc.2024.117899_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113697","article-title":"Analgesic and anti-inflammatory articular effects of essential oil and camphor isolated from ocimum kilimandscharicum G\u00fcrke leaves","volume":"269","author":"dos Santos","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111749","article-title":"Anti-inflammatory and analgesic actions of bufotenine through inhibiting lipid metabolism pathway","volume":"140","author":"Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117899_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113103","article-title":"Anti-inflammatory and analgesic activities of neolamarckia cadamba and its bioactive monoterpenoid indole alkaloids","volume":"260","author":"Yuan","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113811","article-title":"Diverse isoquinolines with anti-inflammatory and analgesic bioactivities from hypecoum erectum","volume":"270","author":"Yuan","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","article-title":"Effects of nonsteroidal anti-inflammatory drugs at the molecular level","volume":"50","author":"Gunaydin","year":"2018","journal-title":"Eurasian J Med"},{"key":"10.1016\/j.bmc.2024.117899_b0490","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1734-1140(10)70308-X","article-title":"Vane\u2019s discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology","volume":"62","author":"Botting","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2024.117899_b0495","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.20424","article-title":"The discovery and development of antiinflammatory drugs","volume":"50","author":"Brune","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bmc.2024.117899_b0500","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117899_b0505","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjp.0702897","article-title":"Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy","volume":"128","author":"Mitchell","year":"1999","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bmc.2024.117899_b0515","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1381612043453144","article-title":"Cyclooxygenase enzymes: regulation and function","volume":"10","author":"Fitzpatrick","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2024.117899_b0520","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117899_b0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1163\/156856005774423809","article-title":"Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing","volume":"13","author":"Peskar","year":"2005","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bmc.2024.117899_b0530","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1073\/pnas.1517642113","article-title":"Systematic study of constitutive cyclooxygenase-2 expression: role of NF-\u039aB and NFAT transcriptional pathways","volume":"113","author":"Kirkby","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117899_b0535","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2012.05.006","article-title":"Inhibition of mitochondrial complex i by various non-steroidal anti-inflammatory drugs and its protection by quercetin via a coenzyme Q-like action","volume":"199","author":"Sandoval-Acu\u00f1a","year":"2012","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2024.117899_b0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117899_b0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcp.2016.09.027","article-title":"Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: a novel gastroprotective mechanism independent of gastric acid suppression","volume":"121","author":"Mazumder","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0550","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/jid.2011.316","article-title":"Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous t-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand","volume":"132","author":"Braun","year":"2012","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.bmc.2024.117899_b0555","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/504230","article-title":"The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells","author":"Farrugia","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bmc.2024.117899_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/0717-6287-47-27","article-title":"Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy","volume":"47","author":"Rosas","year":"2014","journal-title":"Biol Res"},{"key":"10.1016\/j.bmc.2024.117899_b0565","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2125.2004.02198.x","article-title":"Current approaches to prevent NSAID-induced gastropathy - COX selectivity and beyond","volume":"58","author":"Becker","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2024.117899_b0570","first-page":"31","article-title":"Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies","volume":"7","author":"Goldstein","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"issue":"4","key":"10.1016\/j.bmc.2024.117899_b0575","article-title":"Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue","volume":"9","author":"Varga","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.bmc.2024.117899_b0580","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/ph3072291","article-title":"Nonsteroidal anti-inflammatory drugs and the kidney","volume":"3","author":"H\u00f6rl","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2024.117899_b0585","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"COX-1 and COX-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bmc.2024.117899_b0590","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/pgmj.2005.042234","article-title":"COX-2 inhibitors and the heart: are all coxibs the same?","volume":"82","author":"Sooriakumaran","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bmc.2024.117899_b0595","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.49.3.443","article-title":"Cyclooxygenase 2 - implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives","volume":"49","author":"Halter","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bmc.2024.117899_b0600","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/245037","article-title":"Clinical use of aspirin in treatment and prevention of cardiovascular disease","volume":"2012","author":"Dai","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.bmc.2024.117899_b0605","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0066-782X2010000400019","article-title":"Anti-Inflamat\u00f3rios N\u00e3o Esteroides: Efeitos Cardiovasculares, C\u00e9rebro-Vasculares e Renais","volume":"94","author":"Batlouni","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.bmc.2024.117899_b0610","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0066-782X2010000400019","article-title":"Artigo de Revis\u00e3o Vasculares e Renais Artigo de Revis\u00e3o","volume":"94","author":"Batlouni","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.bmc.2024.117899_b0615","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gut.2005.065003","article-title":"COX-2 chronology","volume":"54","author":"Hawkey","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bmc.2024.117899_b0620","first-page":"831","article-title":"Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?","volume":"3","author":"Howes","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.bmc.2024.117899_b0625","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0107","article-title":"Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs","volume":"41","author":"Lucas","year":"2019","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.bmc.2024.117899_b0630","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ph3041279","article-title":"Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: inpatient setting","volume":"3","author":"Dixit","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2024.117899_b0635","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0748233714538484","article-title":"Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats","volume":"32","author":"Burukoglu","year":"2016","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.bmc.2024.117899_b0640","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1155\/2006\/356434","article-title":"Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs","volume":"20","author":"Yan","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.bmc.2024.117899_b0645","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pds.1207","article-title":"A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience","volume":"15","author":"Goldkind","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bmc.2024.117899_b0650","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5604\/01.3001.0010.8633","article-title":"Recent advances in hepatotoxicity of non-steroidal anti-inflammatory drugs","volume":"17","author":"Meunier","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.bmc.2024.117899_b0655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.bmc.2024.117899_b0660","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bmc.2024.117899_b0665","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/hcg138","article-title":"Hepatocellular damage from non-steroidal anti-inflammatory drugs","volume":"96","author":"O\u2019connor","year":"2003","journal-title":"QJM: Int J Med"},{"key":"10.1016\/j.bmc.2024.117899_b0670","first-page":"25","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs","volume":"10","author":"Park","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.bmc.2024.117899_b0675","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rmed.2018.01.002","article-title":"Aspirin exacerbated respiratory disease: current topics and trends","volume":"135","author":"Rodr\u00edguez-jim\u00e9nez","year":"2018","journal-title":"Respir Med"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:19:06Z","timestamp":1725916746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":135,"alternative-id":["S0968089624003134"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117899","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, classification, and adverse effects of NSAIDs: A review on recent advancements","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117899"}}